These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 4994177)

  • 21. Lymphocyte-monocyte defect associated with anergy and recurrent infections.
    Louie JS; Goldberg LS
    Clin Exp Immunol; 1972 Jul; 11(3):469-74. PubMed ID: 4625400
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of C-reactive protein from the eggs of the marine teleost. Cyclopterus lumpus L.
    Fletcher TC; White A; Youngson A; Pusztai A; Baldo BA
    Biochim Biophys Acta; 1981 Nov; 671(1):44-9. PubMed ID: 6796127
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of antilymphocyte serum and antiparablast serum on lymphocyte transformation as immune reaction in leukemic children].
    Zintl F; Aurich G; Plenert W
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1971; 96(1):14-20. PubMed ID: 4110778
    [No Abstract]   [Full Text] [Related]  

  • 24. Quantitative serologic parameters of purified HL-A antigens.
    Kahan BD; Pellegrino MA; Papermaster BW; Reisfeld RA
    Transplant Proc; 1971 Mar; 3(1):227-30. PubMed ID: 4106313
    [No Abstract]   [Full Text] [Related]  

  • 25. C1-esterase inactivator from cancer cells is C-reactive protein.
    Darhovsky D; Ziegenhagen G; Duchmann H
    Lancet; 1980 Jan; 1(8160):149-50. PubMed ID: 6101479
    [No Abstract]   [Full Text] [Related]  

  • 26. Two monoclonal antibodies (DLy-1 and DLy-6) directed against canine lymphocytes.
    Wulff JC; Durkopp N; Aprile J; Tsoi MS; Springmeyer SC; Deeg HJ; Storb R
    Exp Hematol; 1982 Aug; 10(7):609-19. PubMed ID: 6813131
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diazotized m-aminobenzyloxymethylcellulose as the insoluble matrix for an immunoadsorbent used in the purification of antigens and antibodies.
    Davis RV; Blanken RM; Beagle RJ
    Biochemistry; 1969 Jul; 8(7):2706-11. PubMed ID: 4185496
    [No Abstract]   [Full Text] [Related]  

  • 28. Circulating immune complexes in inflammatory bowel disease.
    Jewell DP; MacLennan IC
    Clin Exp Immunol; 1973 Jun; 14(2):219-26. PubMed ID: 4197968
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of human F(ab') 2 fragments as blocking agents in the mixed lymphocyte reaction.
    Hornung MO; Layne E; McDonald JC
    J Immunol; 1971 Oct; 107(4):979-84. PubMed ID: 4999263
    [No Abstract]   [Full Text] [Related]  

  • 30. Immunological studies on malignant melanomas of man.
    Romsdahl MM; Cox IS
    Yale J Biol Med; 1973 Dec; 46(5):693-701. PubMed ID: 4205125
    [No Abstract]   [Full Text] [Related]  

  • 31. Isolation of lipid-free C-reactive protein by affinity chromatography.
    Coll JM
    Rev Esp Fisiol; 1989 Sep; 45(3):291-6. PubMed ID: 2616877
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative studies on the binding properties of human and rabbit C-reactive proteins.
    Oliveira EB; Gotschlich EC; Liu TY
    J Immunol; 1980 Mar; 124(3):1396-402. PubMed ID: 6766973
    [No Abstract]   [Full Text] [Related]  

  • 33. Interaction of C-reactive protein complexes with the complement system. II. Consumption of guinea pig complement by CRP complexes: requirement for human C1q.
    Volanakis JE; Kaplan MH
    J Immunol; 1974 Jul; 113(1):9-17. PubMed ID: 4208926
    [No Abstract]   [Full Text] [Related]  

  • 34. Dynamic aspects of the interaction between antibodies and complement at the cell surface.
    Sundqvist KG; Svehag SE; Thorstensson RT
    Scand J Immunol; 1974; 3(3):237-50. PubMed ID: 4211939
    [No Abstract]   [Full Text] [Related]  

  • 35. Relationship of C-reactive protein in autologous plasma of cancer patients and choline phosphate in lymphocyte responses to phytohemagglutinin.
    Oishi N; Torikawa C; Ochiai H; Hokama Y
    J Reticuloendothel Soc; 1973 Sep; 14(3):242-9. PubMed ID: 4200874
    [No Abstract]   [Full Text] [Related]  

  • 36. Histocompatibility typing by cytotoxic lymphocytes. The HLA-A2-28, B5-w35 serologically cross-reactive groups reviewed by cytotoxic lymphocytes.
    Kristensen T; Malissen B; Charmot D; Mawas C; Kissmeyer-Nielsen F
    Tissue Antigens; 1981 May; 17(5):464-72. PubMed ID: 7336413
    [No Abstract]   [Full Text] [Related]  

  • 37. Purification of C-reactive protein from Channa punctatus (Bloch).
    Mitra S; Bhattacharya S
    Indian J Biochem Biophys; 1992 Dec; 29(6):508-11. PubMed ID: 1294470
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro generation of cytotoxicity against autologous human tumour biopsy cells.
    Vose BM; Vánky F; Fopp M; Klein E
    Int J Cancer; 1978 May; 21(5):588-93. PubMed ID: 659024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serologic homology between H-2 and HL-A system.
    David CS; Klein J; Shreffler DC
    Transplant Proc; 1973 Mar; 5(1):461-6. PubMed ID: 4633089
    [No Abstract]   [Full Text] [Related]  

  • 40. Purification of C-reactive protein.
    Ikuta T; Okubo H; Yukimura H; Ishibashi H
    Biochem Int; 1983 Feb; 6(2):275-82. PubMed ID: 6433926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.